$50 million for innovative research into mental health, melanoma and more

The search for a multi-season flu vaccine, better treatment for schizophrenia, and how gut microorganisms may fight off melanoma, are 3 projects sharing in $50 million in health research funding from the Australian Government.

The Hon Mark Butler MP
Minister for Health and Aged Care

Media event date:
Date published:
Media type:
Media release
Audience:
General public

The search for a multi-season flu vaccine, better treatment for schizophrenia, and how gut microorganisms may fight off melanoma, are 3 projects sharing in $50 million in health research funding from the Australian Government.
 
Ten projects will bring together outstanding teams from across health and medical research disciplines to work together to answer major questions that cannot be answered by a single investigator.
 
The $50 million in funding will support new discoveries in a range of health and medical areas, covering the spectrum from basic science to clinical medicine, public health and health services research.
 
Associate Professor Joanna Groom of WEHI (formerly Walter and Eliza Hall Institute of Medical Research) will lead a multidisciplinary team to rethink current vaccine design approaches and further the search for a long-lived and multi-season flu vaccine.
 
The research hopes to reveal how to best promote long-lived protection against respiratory viral infections that emerge and mutate quickly, like influenza and coronaviruses.
 
Despite previous research, vaccines that consistently induce long-lasting protection remain elusive. This reduces protection, increases the need for booster shots, and which imposes large socioeconomic costs and reduces vaccine compliance.
 
Associate Professor Groom’s approach will establish the mechanistic ‘rules’ to produce the first unified model of long-lived vaccine response that induces broad and durable immunity against viral infections.
 
Deakin University researcher Professor Michael Berk will lead a project which aims to discover new treatments for schizophrenia.
 
The Synergy for the Development of Innovative Clinical Treatments in Schizophrenia (SYNDICAT) project will generate new evidence that will position Australia as a world leader in psychiatric treatment discovery and will foster a new generation of mental health researchers. This will provide people with schizophrenia and their carers hope of improved quality of life and renewed ability to contribute to their families, workplaces, and society.
 
Associate Professor Shahneen Sandhu of The University of Melbourne will lead a team exploring how microorganisms in the gut produce key factors involved in immune responses against melanoma.
 
Melanoma is Australia’s third most commonly diagnosed cancer.
 
This project will bring together immunologists, microbial ecologists, computational biologists, and clinicians to identify new therapeutic approaches to improve outcomes in patients with melanoma.
 
The $50m in funding is provided through the National Health and Medical Research Council’s (NHMRC) 2024 Synergy Grant scheme.
 
Further information on the 2024 Synergy Grants projects can viewed on NHMRC’s website and here.
 
Quotes attributable to Minister Butler:
 
“With this $50 million, the Albanese Government is investing in Australia’s world-class researchers to solve some of the hardest problems in health, including the search for a multi-season flu vaccine, better treatment for schizophrenia, and how gut microorganisms may fight off melanoma.
 
“The best research discoveries are rarely the work of one person, working alone. These $5 million grants bring together researchers across fields of expertise to answer some of health’s most difficult questions.”
 
“Australia’s health and medical researchers are world-leading and these projects are proof of that.”
 
Quotes attributable to NHMRC CEO Professor Steve Wesselingh:
 
“NHMRC has a track record of funding research that fosters collaboration and builds capacity in the health and medical research workforce.
 
“Synergy Grants provide a special opportunity for highly collaborative teams of diverse researchers to work together to address major problems in human health.
 
“The scheme creates a strong foundation for researchers, of all backgrounds, to cross-pollinate and take on truly innovative projects – creating an even stronger next generation of Australian health and medical researchers.”

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.